SCHEMBL31669378

SCHEMBL31669378

N[C@@H]1CCN(C(=O)Oc2cccc3ccccc23)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ GAA P10253 2/20 0.51
▸ NPC1 O15118 3/20 0.46
▸ TP53 P04637 3/20 0.46
▸ NCEH1 Q6PIU2 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ BCHE P06276 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HPGD P15428 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31669414 0.87 RAB9A (0.50) RAB9AL3MBTL1KMT2AMEN1SMN1; SMN2
SCHEMBL31669155 0.82 TP53 (0.44) RAB9ASMN1; SMN2ALDH1A1GAANPC1
SCHEMBL31669152 0.82 TP53 (0.44) RAB9AKMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL31669191 0.82 EPHX1 (0.46) RAB9AKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL31669375 0.81 GAA (0.41) RAB9AL3MBTL1SMN1; SMN2GAANPC1
SCHEMBL31669183 0.80 KDM4E (0.54) L3MBTL1KMT2AMEN1ALDH1A1LMNA
SCHEMBL31669098 0.79 SMN1; SMN2 (0.41) RAB9AL3MBTL1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL31669103 0.79 TP53 (0.42) KMT2AMEN1SMN1; SMN2ALDH1A1GAA
SCHEMBL20887175 0.77 SMN1; SMN2 (0.79) RAB9AL3MBTL1KMT2AMEN1SMN1; SMN2
SCHEMBL31669154 0.77 GAA (0.63) RAB9AKMT2AMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors MERTK, RET, ERBB2 RAB9A 1364/4885L3MBTL1 1353/4885KMT2A 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback